Decrease in ribosomal density of Proteus mirabilis exposed to subinhibitory concentrations of ampicillin or cephalothin.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 1096166)

Published in Proc Soc Exp Biol Med on July 01, 1975

Authors

V Lorian, L D Sabath, M Simionescu, D W Watson

Articles by these authors

Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother (1975) 17.12

Cephalosporinase and penicillinase activities of a beta-lactamase from Pseudomonas pyocyanea. Biochem J (1965) 12.54

A new type of penicillin resistance of Staphylococcus aureus. Lancet (1977) 9.15

Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma. J Lab Clin Med (1971) 8.13

Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins. Antimicrob Agents Chemother (1975) 6.82

Galloylglucoses of low molecular weight as mordant in electron microscopy. I. Procedure, and evidence for mordanting effect. J Cell Biol (1976) 5.27

Puffing frequency and nicotine intake in cigarette smokers. Br Med J (1970) 4.69

Suppression of intrinsic resistance to methicillin and other penicillins in Staphylococcus aureus. Antimicrob Agents Chemother (1972) 3.88

A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock. J Exp Med (1970) 3.76

Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin Infect Dis (2004) 3.69

COMPLEMENT FIXATION WITH THE NEUROTROPIC VIRUSES. J Exp Med (1943) 3.65

Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics. Antimicrob Agents Chemother (1976) 3.59

Chemical and physical factors influencing methicillin resistance of Staphylococcus aureus and Staphylococcus epidermidis. J Antimicrob Chemother (1977) 3.56

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis (1997) 3.29

Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. JAMA (1978) 3.13

Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro. Antimicrob Agents Chemother (1973) 3.05

Biological activities of lipid A complexed with bovine-serum albumin. Eur J Biochem (1972) 3.04

Comparison of the antibacterial activity of rifampicin and other antibiotics. Am J Med Sci (1968) 3.03

The problems of drug-resistant pathogenic bacteria. Factors influencing methicillin resistance in staphylococci. Ann N Y Acad Sci (1971) 2.96

Permeability of intestinal capillaries. Pathway followed by dextrans and glycogens. J Cell Biol (1972) 2.80

Effect of protein A on staphylococcal opsonization. Infect Immun (1977) 2.79

Effect of pH on the activity of erythromycin against 500 isolates of gram-negative bacilli. Appl Microbiol (1970) 2.75

Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis. J Cell Biol (1986) 2.73

Rapid microassay for circulating nephrotoxic antibiotics. Antimicrob Agents Chemother (Bethesda) (1970) 2.73

Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains. Immunology (1977) 2.73

Purification and characterization of group A streptococcal pyrogenic exotoxin type C. Infect Immun (1977) 2.59

Synergy of antibacterial substances by apparently known mechanisms. Antimicrob Agents Chemother (Bethesda) (1967) 2.56

Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria. Appl Microbiol (1968) 2.55

Synergistic combinations of penicillins in the treatment of bacteriuria. N Engl J Med (1967) 2.53

Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization. J Lab Clin Med (1968) 2.45

In vitro activity of cephalosporins against methicillin-resistant, coagulase-negative staphylococci. J Infect Dis (1978) 2.39

Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun (1978) 2.35

Ontogeny of the immune response. I. Development of immunoglobulins in germfree and conventional colostrum-deprived piglets. J Immunol (1966) 2.28

Differentiated microdomains on the luminal surface of the capillary endothelium. I. Preferential distribution of anionic sites. J Cell Biol (1981) 2.27

Heterogeneity of group A streptococcal pyrogenic exotoxin type B. Infect Immun (1978) 2.26

Differentiated microdomains on the luminal surface of capillary endothelium: distribution of lectin receptors. J Cell Biol (1982) 2.23

Segmental differentiations of cell junctions in the vascular endothelium. The microvasculature. J Cell Biol (1975) 2.22

Differentiated microdomains on the luminal surface of the capillary endothelium. II. Partial characterization of their anionic sites. J Cell Biol (1981) 2.18

Host-parasite relationships among group A streptococci. IV. Suppression of antibody response by streptococcal pyrogenic exotoxin. J Bacteriol (1968) 2.16

Further purification of group A streptococcal pyrogenic exotoxin and characterization of the purified toxin. Infect Immun (1976) 2.08

Thiol-group binding of zinc to a beta-lactamase of Bacillus cereus: differential effects on enzyme activity with penicillin and cephalosporins as substrates. J Bacteriol (1968) 2.08

Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus. Ann Intern Med (1982) 2.05

Role of antibodies in reactions to gram-negative bacterial endotoxins. Ann N Y Acad Sci (1966) 2.02

Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. Int Immunol (1998) 1.96

Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock. Infect Immun (1978) 1.96

Enhanced immune response after immunosuppression by Streptococcal pyrogenic exotoxin. Infect Immun (1973) 1.92

Rapid microassays for clindamycin and gentamicin when present together and the effect of pH and of each on the antibacterial activity of the other. Antimicrob Agents Chemother (1974) 1.92

Biologically active endotoxins from Salmonella mutants deficient in O- and R-polysaccharides and heptose. J Bacteriol (1967) 1.92

Antimicrobial agent susceptibility patterns of bacteria in hospitals from 1971 to 1982. J Clin Microbiol (1984) 1.91

Effect of lymphocytes from patients with ulcerative colitis on human adult colon epithelial cells. Gastroenterology (1966) 1.91

Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin. Infect Immun (1979) 1.88

Resistance of penicillins and cephalosporins to beta-lactamases from Gram-negative bacilli: some correlations with antibacterial activity. Ann N Y Acad Sci (1967) 1.88

Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ. J Cell Biol (1983) 1.86

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol (1997) 1.82

Permeability of muscle capillaries to exogenous myoglobin. J Cell Biol (1973) 1.79

Production of pyrogenic exotoxin by groups of streptococci: association with group A. J Infect Dis (1979) 1.77

Structural aspects of the permeability of the microvascular endothelium. Acta Physiol Scand Suppl (1979) 1.77

Abnormal forms of bacteria produced by antibiotics. Am J Clin Pathol (1975) 1.75

Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistance. Diagn Microbiol Infect Dis (1992) 1.74

Some effects of subinhibitory concentrations of antibiotics on bacteria. Bull N Y Acad Med (1975) 1.74

Zinc as a cofactor for cephalosporinase from Bacillus cereus 569. Biochem J (1966) 1.74

Some effect of subinbilitory concentrations of penicillin on the structure and division of staphylococci. Antimicrob Agents Chemother (1975) 1.72

The assay of antimicrobial compounds. Hum Pathol (1976) 1.69

Cephalosporinase and penicillinase activity of Bacillus cereus. Antimicrob Agents Chemother (Bethesda) (1965) 1.68

Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents. Antimicrob Agents Chemother (1976) 1.65

Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes. Infect Immun (1976) 1.63

Independent segregation of chloramphenicol resistance in Staphylococcus aureus. Antimicrob Agents Chemother (Bethesda) (1967) 1.63

Morphometric data on the endothelium of blood capillaries. J Cell Biol (1974) 1.62

Transplacental passage of erythromycin and clindamycin. N Engl J Med (1973) 1.59

Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved. Infect Immun (1978) 1.58

Effects of subinhibitory concentrations of antibiotics on cross walls of cocci. Antimicrob Agents Chemother (1976) 1.57

Use of a heavy inoculum in the in vitro evaluation of the anti-staphylococcal activity of 19 cephalosporins. Antimicrob Agents Chemother (1978) 1.57

Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ Res (1986) 1.55

Ontogeny of the immune response. II. Characterization of 19S-gamma-G- and 7S-gamma-G-immunoglobulins in the true primary and secondary responses in piglets. J Immunol (1966) 1.54

Pneumococci producing beta hemolysis on agar. Appl Microbiol (1972) 1.52

Nonspecific T-lymphocyte mitogenesis by pyrogenic exotoxins from group A streptococci and Staphylococcus aureus. Infect Immun (1979) 1.51

Cell wall composition and associated properties of methicillin-resistant Staphylococcus aureus strains. J Bacteriol (1978) 1.51

Structural basis of permeability in sequential segments of the microvasculature of the diaphragm. II. Pathways followed by microperoxidase across the endothelium. Microvasc Res (1978) 1.50

Susceptibility of pneumococci and Haemophilus influenzae to antibacterial agents. Antimicrob Agents Chemother (1976) 1.49

Synergistic penicillin combinations for treatment of human urinary-tract infections. Antimicrob Agents Chemother (Bethesda) (1966) 1.48

Preferential distribution of anionic sites on the basement membrane and the abluminal aspect of the endothelium in fenestrated capillaries. J Cell Biol (1982) 1.47

Antagonism of the antibacterial action of some penicillins by other penicillins and cephalosporins. J Clin Invest (1975) 1.45

Penicillins and cephalosporins: differences in morphologic effects on Proteus mirabilis. J Infect Dis (1972) 1.45

Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am J Pathol (1986) 1.45

In vitro activity of cefazolin against recent clinical bacterial isolates. J Infect Dis (1973) 1.42

Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin. Infect Immun (1979) 1.41

Alteration of clearance function by group A streptococcal pyrogenic exotoxin and its relation to suppression of the antibody response. Infect Immun (1978) 1.40

Rings of membrane sterols surround the openings of vesicles and fenestrae, in capillary endothelium. J Cell Biol (1983) 1.40

Altered cell walls of Staphylococcus aureus resistant to methicillin. Nature (1970) 1.39

Galloylglucoses of low molecular weight as mordant in electron microscopy. II. The moiety and functional groups possibly involved in the mordanting effect. J Cell Biol (1976) 1.38

Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin. Infect Immun (1973) 1.38

Increasing the usefulness of antibiotics: Treatment of infections caused by gram-negative bacilli. Clin Pharmacol Ther (1970) 1.38

Isolation of Chlamydia trachomatis from the lower respiratory tract of adults. Lancet (1980) 1.37

Pneumococcal beta hemolysin produced under the effect of antibiotics. Appl Microbiol (1973) 1.35

Direct cord reading medium for isolation of mycobacteria. Appl Microbiol (1966) 1.35

Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Hum Immunol (2001) 1.33

Pyrogenic specificity of streptococcal exotoxins, staphylococcal enterotoxin, and gram-negative endotoxin. Infect Immun (1974) 1.31

Histamine receptors of the microvascular endothelium revealed in situ with a histamine-ferritin conjugate: characteristic high-affinity binding sites in venules. J Cell Biol (1982) 1.31